CARDIOMETABOLIC HEALTH CONGRESS

Cardiovascular Disease

As the leading cause of death worldwide, cardiovascular disease is one of the most debilitating and well-recognized manifestations of cardiometabolic decline. Coronary artery disease, heart failure, peripheral artery disease, and arrhythmia are just some cardiovascular diseases that lead to lower quality of life, increased mortality, and significant health care costs.

CME Activities

Available courses, certification information, and the latest educational opportunities for practitioners interested in beginning or continuing their careers in a cardiometabolic subspecialty with emphasis on cardiovascular disease.

Cardiometabolic

Ironing Out the Data: Iron Deficiency in Heart Failure

Cardiometabolic

Addressing and Treating Iron Deficiency in Patients with Heart Failure

News Digest

The latest industry news, CMHC Pulse Blogs and Cardiometabolic Chronicle articles related to cardiovascular disease.

The Digital Revolution in Diabetes Care: Turning Clinical Challenges into Patient Success

Read on for the current challenges and actionable steps to integrate CGM and other digital tools into diabetes care.

Cardiovascular Updates from AHA Congress 2024

Get cardiovascular updates from AHA Congress 2024. Read on for eight late breaking science updates and more!

Your Top Five Questions About CMHC On-Demand, Answered

Top 5 CMHC On Demand Questions Answered! Make the most of this resource and stay updated on key developments in cardiometabolic health.

What Cardiometabolic Clinicians Can Be Thankful For This Year

This year, cardiometabolic clinicians have witnessed remarkable advancements for treating patients. Discover now!

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

Read on for 5 takeaways from the 19th Annual Cardiometabolic Health Congress - from Dr. Libby's insights to innovations in renal protection!

MASH and Cardiometabolic Health: Pharmacotherapy and Emerging Therapies (Part 2)

Read on for pharmacotherapy, emerging treatments, & practical strategies for managing MASH in complex patients!

MASH and Cardiometabolic Health: Practical Treatments for Managing Complex Patients (Part 1)

Understand key treatment approaches for MASH to stay informed and deliver evidence-based care. Start reading now!

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

What happened at the 19th Annual CMHC? Get daily highlights, event photos, and read a poignant quote from keynote Dr. Peter Libby.

Rest, Revive, Repeat: Why Sleep is Critical for Cardiometabolic Health

Understand the profound connection between sleep disorders and cardiometabolic health. Discover the key to cardiometabolic health!

Day 4 Nightly News: 18th Annual CMHC

Day 3 Nightly News: 18th Annual CMHC

Day 2 Nightly News: 18th Annual CMHC

Day 1 Preconference Nightly News: 18th Annual CMHC

Clinical Brief: The Disproportionate Burden of ATTR-CM in African Americans

FDA Approves First SGLT1/SGLT2 Inhibitor Sotagliflozin

Cardiovascular Outcomes with Colchicine

Colchicine is an anti-inflammatory drug derived from Colchicum autumnale, a toxic autumn-blooming flowering plant commonly known as autumn crocus or meadow saffron. The alkaloid is

Sleep Insights with Dr. Lee Surkin

In honor of World Sleep Day 2023, we sat down with Cardiometabolic Health Congress (CMHC) faculty member Lee A. Surkin, MD, founder of the American

Baxdrostat for Treatment-Resistant Hypertension

Investigators reported that baxdrostat – at several dose levels – reduced plasma aldosterone levels but not cortisol levels in results from the recent BrigHTN study

2022 News in Review: Top 10 Stories in Cardiorenal Metabolic Health

The experts at Cardiometabolic Health Congress (CMHC) have selected the TOP 10 developments, approvals, news, and findings from 2022 that impact the field of cardiorenal

Conference Recap: 17th Annual Cardiometabolic Health Congress

Hundreds of practitioners gathered at the Boston Park Plaza for the annual conference from Cardiometabolic Health Congress (CMHC) on Oct. 19-22, 2022. Founded in 2006,

Nightly News: DAY ONE of the 17th Annual CMHC

Hundreds of practitioners gathered today at the Boston Park Plaza for the annual conference from Cardiometabolic Health Congress (CMHC). In the past 17 years, this

Expert Highlights and Perspectives

A cache of recorded faculty presentations addressing the diagnosis, clinical management, treatment, and emerging strategies related to cardiovascular disease.

Identifying and Addressing Elevated Sodium Intake to Decrease Cardiovascular Risk

In this webcast, multidisciplinary experts engage in meaningful discussions about strategies to minimize the impact of total daily sodium intake on CVD risk. Recorded on May 4, 2023.

Iron Deficiency in Heart Failure: An Overview (recorded July 2022)

Screening and Diagnosis of Iron Deficiency in Heart Failure (recorded July 2022)

Treatment of Iron Deficiency: Clinical Trials & Evidence (recorded July 2022)

Expert Discussions: The Role of IV Iron in Patients with HF (recorded July 2022)

Challenging Cases in Patients with Iron Deficiency and Heart Failure (recorded July 2022)

A Call to Action: Women and Peripheral Artery Disease

Roxana Mehran, MD, Professor of Medicine at Mount Sinai and an internationally-recognized expert, covers the current disparities in the underdiagnosis and undertreatment of peripheral artery disease (PAD) in women, as well as advances and clinical pearls to improve the care of women with PAD (recorded August 2023).

Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?

Watch as CMHC Chair Christie M. Ballantyne, MD moderates an engaging interview with Pam R. Taub, MD, and Salim S. Virani, MD, PhD, recapping a debate at 2022 CMHC Spring titled “Drawing the Line Between Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?” (recorded April 2022).

Diabetes and the Increase Risk of Atherothrombotic Events

INTERVIEW #1

Increased platelet aggregation & activation in diabetes patients
Reduced responsiveness to commonly-used antiplatelet agents
The role of antiplatelet therapy in patients with diabetes
Summary and contextualization of THEMIS & THEMIS-PCI trials

How Do These Advances Fit in With Existing Therapies and Other Updates in Secondary Prevention in Diabetes Patients?

INTERVIEW #2

Going beyond glucose in diabetes
Multifactorial risk reduction
SGLT-2 inhibitors & recent updates

Advances in Dual Pathway Inhibition in Diabetes Patients

INTERVIEW #3

Overlap between dual antiplatelet therapy (DAPT) and dual pathway inhibition (DPI)
Which form of double antithrombotic agent/regimen should be used in patient
Integrating and interpreting the data from COMPASS and THEMIS/THEMIS-PCI

The Screening, Diagnosis, and Medical Treatment of PAD: A Detailed Overview

Watch as our faculty and PAD experts Marc Bonaca, MD and Sonia Anand, MD, cover in detail the screening, diagnosis, and medical management of PAD, as part of our Interventional Cardiology Masterclass

(recorded January 29, 2022).

Watch Drs. Bhatt, Bonaca, and Patel recap the symposium at 2021 CMHC Spring, as well as discuss some recent data on antithrombotic therapy for PAD that were presented at 2021 American College of Cardiology meeting, including:

The concept and the rationale of total (first and subsequent) events in PAD
Total vascular events in the VOYAGER-PAD trial: efficacy and safety
Implications of these recent sub-analyses
Dual antiplatelet therapy (DAPT) vs. dual platelet inhibition (DPI):
patient selection and strategies

Watch as experts Deepak Bhatt, MD, Marc Bonaca, MD, and Manesh Patel, MD, discuss additional clinical pearls from the 2020 CMHC Annual Meeting on the management of high-risk peripheral artery disease patients, including:

Summary of the main results of the COMPASS and VOYAGER-PAD trials
Summary of sub-analyses of these trials
Take home points and practice implications

CMHC | Bonaca ESC 2021 Interview

CMHC | Bonaca Interview

Patient Story: Considering Iron Deficiency in Heart Failure

Andy Y. Lee, MD, heart failure cardiologist and Assistant Clinical Professor at University of California Irvine School of Medicine, shares his story about a HF patient with ID.

Iron Deficiency in Heart Failure with Dr. Panjrath

Iron Deficiency in Heart Failure with Dr. Bozkurt

Iron Deficiency in Heart Failure with Dr. Ponikowski

Resources

A collection of resources related to cardiovascular disease for both patients and provider education and connection.

Digital Pathway Education

Navigating the Diagnosis and Management of Heart Failure in Women

View Now

Peer To Peer Toolkit

Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments

Download Now

Peer To Peer Toolkit

A compilation of key content from the Primetime Symposium at the 2020 15th Annual CMHC Live Online

Download Now

A compilation of key content from the Primetime Symposium at 2021 CMHC Spring

Read Now

Dual Pathway Inhibition: Mechanistic Rationale for Atherothrombotic Risk Reduction

View Now

Clinical Brief

The Disproportionate Burden of ATTR-CM In African Americans

Download Now

Drug Pipeline

Key emerging approaches across the spectrum of cardiovascular disease that are being studied in various stages of clinical trials, or that were recently approved by the U.S. Food and Drug Administration for therapeutic use.

Subscribe to "The Monthly Beat" Newsletter

Click to Subscribe

Quick Links

Professional Education

Cardiometabolic Health Congress
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431

First Name

Last Name

Company / Practice Name

Area of Focus / Specialty

Phone

Cardiovascular Disease

CME Activities

News Digest

The Digital Revolution in Diabetes Care: Turning Clinical Challenges into Patient Success

Cardiovascular Updates from AHA Congress 2024

Your Top Five Questions About CMHC On-Demand, Answered

What Cardiometabolic Clinicians Can Be Thankful For This Year

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

MASH and Cardiometabolic Health: Pharmacotherapy and Emerging Therapies (Part 2)

MASH and Cardiometabolic Health: Practical Treatments for Managing Complex Patients (Part 1)

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Rest, Revive, Repeat: Why Sleep is Critical for Cardiometabolic Health

article

article

article

article

article

article

article

article

article

article

article

article

Expert Highlights and Perspectives

Identifying and Addressing Elevated Sodium Intake to Decrease Cardiovascular Risk

Iron Deficiency in Heart Failure: An Overview (recorded July 2022)​

Screening and Diagnosis of Iron Deficiency in Heart Failure (recorded July 2022)

Treatment of Iron Deficiency: Clinical Trials & Evidence (recorded July 2022)

Expert Discussions: The Role of IV Iron in Patients with HF (recorded July 2022)

Challenging Cases in Patients with Iron Deficiency and Heart Failure (recorded July 2022)

A Call to Action: Women and Peripheral Artery Disease

Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?

Diabetes and the Increase Risk of Atherothrombotic Events

How Do These Advances Fit in With Existing Therapies and Other Updates in Secondary Prevention in Diabetes Patients?

Advances in Dual Pathway Inhibition in Diabetes Patients

The Screening, Diagnosis, and Medical Treatment of PAD: A Detailed Overview

Watch Drs. Bhatt, Bonaca, and Patel recap the symposium at 2021 CMHC Spring, as well as discuss some recent data on antithrombotic therapy for PAD that were presented at 2021 American College of Cardiology meeting, including:

Watch as experts Deepak Bhatt, MD, Marc Bonaca, MD, and Manesh Patel, MD, discuss additional clinical pearls from the 2020 CMHC Annual Meeting on the management of high-risk peripheral artery disease patients, including:

CMHC | Bonaca ESC 2021 Interview

CMHC | Bonaca Interview

Patient Story: Considering Iron Deficiency in Heart Failure

Iron Deficiency in Heart Failure with Dr. Panjrath

Iron Deficiency in Heart Failure with Dr. Bozkurt

Biykem Bozkurt MD, PhD, FHFSA, FACC, FACP

Iron Deficiency in Heart Failure with Dr. Ponikowski

Prof. Piotr Ponikowski MD, PhD, FESC

Iron Deficiency in Heart Failure with Dr. Ponikowski

Prof. Piotr Ponikowski MD, PhD, FESC

Interventional Cardiology

Resources

Other Resources

Digital Pathway Education

Peer To Peer Toolkit

Peer To Peer Toolkit

Clinical Brief

Drug Pipeline

Heart Failure

MI/post-ACS

Antithrombotics

Peripheral Artery Disease (PAD)

Other

Subscribe to "The Monthly Beat" Newsletter

Professional Education

QUICK LINKS

Professional Education

Industry Resources

Subscribe

Iron Deficiency in Heart Failure: An Overview (recorded July 2022)

Biykem Bozkurt
MD, PhD, FHFSA, FACC, FACP

Prof. Piotr Ponikowski
MD, PhD, FESC

Prof. Piotr Ponikowski
MD, PhD, FESC